Home / Almujtama Alraida Medical Co. / 2024 Annual Results

Almujtama Alraida Medical Co. 2024 Annual Results

Revenue

SAR 431M

Net Profit

SAR 8M

EPS

SAR 0.83

Operating Cash Flow

SAR 51M

Almujtama Alraida Medical Co. (9592) reported full year 2024 revenue of SAR 431M, up 5.6% from SAR 408M in 2023. Net profit came in at SAR 8M, down 30.4% year on year. Earnings per share were SAR 0.83. The company generated SAR 51M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 6.48 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 6.48.

Key Financial Metrics

Metric	2024	2023
Revenue	SAR 431M	SAR 408M
Net Profit	SAR 8M	SAR 11M
Net Margin	1.8%	2.8%
ROE	5.7%	8.8%
EPS	SAR 0.83	SAR 1.20
Total Assets	SAR 459M	SAR 442M
Total Equity	SAR 138M	SAR 130M
Total Liabilities	SAR 321M	SAR 312M
Operating Cash Flow	SAR 51M	SAR 68M

Year on Year Comparison

Revenue increased by 5.6% compared to 2023. Net profit decreased by 30.4%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2025 2024 2023 2022

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-03-27.